NDC 0078-0683 – Arranon

Nelarabine 5 mg/mL · Injection · Intravenous

Human Prescription Drug

Product NDC0078-0683

Product details

Brand name
Arranon
Generic name
Nelarabine
Labeler
Novartis Pharmaceuticals Corporation
Dosage form
Injection
Route
Intravenous
Marketing category
NDA · NDA021877
Marketed since
October 5, 2016
Marketing end
September 30, 2026
Pharmacologic class
Nucleoside Metabolic Inhibitor

Active ingredients

Uses, dosage, side effects and warnings for Arranon →

Package NDC codes (1)

Package NDCDescriptionSince
0078-0683-6150 mL in 1 VIAL (0078-0683-61)Aug 2, 2019

Other Arranon products